BMEA biomeafusion.com Net earnings per share for the last 12 months

Biomea Fusion, Inc. (BMEA) plans to generate revenue through the implementation of BMF-219 covalent inhibitors to combat oncology and diabetes. Annual net income per share reflects the dynamics of this process, where -0.31 captures the current state of the parameter. The issuer monetizes its intellectual property via enzyme modulation, delegating research to external laboratories without losing control over its patents.

BMEA (Biomea Fusion Corp) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Biomea Fusion Corp (BMEA)

- stock price and consensus target price:

Stock Price Biomea Fusion Corp|BMEA - Average Forecast Price

- market capitalization data:

Market Valuation Biomea Fusion, Inc.|BMEA - Aggregate Business Value

- balance sheet net asset value indicators:

Book Value per Share Biomea Fusion|BMEA - Book Capitalization|Market Capitalization to Book Value Ratio biomeafusion.com|BMEA - Aggregate Company Assets

- business debt structure and liquidity details:

- net income and valuation multiples indicators:

BMEA - Net Income|Projected Future Earnings Biomea Fusion, Inc.|BMEA - Price to Earnings Ratio|Forward P/E Multiple Biomea Fusion Corp|BMEA - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biomea Fusion, Inc.|BMEA - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Biomea Fusion|BMEA - Net earnings per share for the last 12 months|Quarterly EPS earnings growth biomeafusion.com|BMEA - Earnings per share growth rate in current year|Earnings growth forecast for next year Biomea Fusion, Inc.

- sales and revenue data:

BMEA - Revenue and Sales Volume|Company Future Sales Volume Biomea Fusion|BMEA - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Biomea Fusion Inc|BMEA - Trailing Twelve Months Sales Growth

Fundamental company valuation:Biomea Fusion Inc (BMEA)

The stability of the healthcare sector and the insulation of metabolic disease research from geopolitical risks create a predictable backdrop for the valuation of Biomea Fusion, Inc. (BMEA). By analyzing the rolling annual earnings per share, an investor can see the final financial result distributed across the total share issuance, allowing for an objective comparison of current business yields against market offerings and a determination of the asset's premium.

Competitors of Biomea Fusion, Inc.

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx Corp|Rezolute Bio (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months lexpharma.com (LXRX)|Net earnings per share for the last 12 months MBX Biosciences Inc MBX|Earnings per share for the last twelve months Altimmune ALT|Net earnings per share (EPS TTM) Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters BioAge Labs, Inc BIOA|QNCX: Net earnings per share (EPS TTM)|Fractyl Health, Inc. (GUTS) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months VTVT|Agape ATP Corporation - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS